Home › Asset managers › Compare 2024-2025 › John Hancock vs Invesco
John Hancock 2024-2025 · Invesco 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 11,767 | 10,089 | 735 | 943 | 93.2% | 90.8% |
| Board proposals | 9,482 | 8,187 | 677 | 618 | 92.4% | 90.4% |
| E&S shareholder proposals | 236 | 114 | 13 | 109 | 89.8% | 81.6% |
| Other items | 2,049 | 1,788 | 45 | 216 | 97.5% | 93.7% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,295 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | John Hancock | Invesco |
|---|---|---|---|---|---|---|
| BOX INC. | June 27, 2025 | To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan to increase the number of shares reserved for issuance by 5,000,000 shares. Compensation |
Board | For | AGAINST 4 funds |
FOR 4 funds |
| BOYD GAMIN | May 8, 2025 | Advisory vote on executive compensation. Say-on-Pay |
Board | Not determined | FOR 6 funds |
AGAINST 8 funds |
| BRANDYWINE REALTY TRUST | May 21, 2025 | Adoption of an amendment to the 2023 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 4 funds |
| BRAZE INC. | June 26, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 7 funds |
| BRIDGEBIO PHARMA INC. | June 20, 2025 | To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 5,000,000 shares. Compensation |
Board | For | AGAINST 5 funds |
FOR 7 funds |
| BRIDGEWATER BANCSHARES INC. | April 22, 2025 | Approve, on a non-binding advisory basis, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 3 funds |
| BRIGHTVIEW HOLDINGS INC. | March 4, 2025 | To approve a non-binding advisory resolution approving the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 5 funds |
| BROADRIDGE FINANCIAL SOLUTIONS INC. | November 14, 2024 | Advisory vote to approve the compensation of the Company's Named Executive Officers (the Say on Pay Vote). Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 24 funds |
| BROADSTONE NET LEASE INC | May 1, 2025 | To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers as described in the Company's 2025 proxy statement. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 6 funds |
| BROOKFIELD INFRASTRUCTURE CORP. | June 24, 2025 | Elect Director Jeffrey Blidner Director Elections |
Board | For | ABSTAIN 2 funds |
FOR 1 fund |
| BRUKER CORP. | May 29, 2025 | Approval of the adoption of the Bruker Corporation 2026 Incentive Compensation Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| BURFORD CAPITAL LIMITED | May 14, 2025 | To re-elect Christopher Halmy as director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| BURFORD CAPITAL LIMITED | May 14, 2025 | To re-elect Robert Gillespie as director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| BYRNA TECHNOLOGIES INC. | November 20, 2024 | Approval, by non-binding vote, the Company's executive compensation. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| C.H. ROBINSON WORLDWIDE INC. | May 8, 2025 | To approve the Amended and Restated 2022 Equity Incentive Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 14 funds |
| CALIX INC. | May 8, 2025 | To approve, on a non-binding, advisory basis, Calix's named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 6 funds |
| CAPRICOR THERAPEUTICS INC. | May 22, 2025 | APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| CAREDX INC. | June 12, 2025 | Approval of an amendment to 2024 Equity Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 7 funds |
| CAREDX INC. | June 12, 2025 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 12 funds |
| CARL ZEISS MEDITEC AG | March 26, 2025 | Approve Remuneration Report Compensation |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| CARL ZEISS MEDITEC AG | March 26, 2025 | Elect Andreas Pecher to the Supervisory Board Director Elections |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| CARL ZEISS MEDITEC AG | March 26, 2025 | Elect Angelika Bullinger-Hoffmann to the Supervisory Board Director Elections |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| CARRIAGE SERVICES INC. | May 13, 2025 | To approve on an advisory basis our 2024 Named Executive Officers' compensation. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 4 funds |
| CARTESIAN THERAPEUTICS INC. | June 13, 2025 | To approve, on a non-binding and advisory basis, a resolution approving the compensation of Cartesian Therapeutics, Inc.'s named executive officers, as described in the accompanying proxy statement under "Executive and Director Compensation." Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| CARVANA CO. | May 5, 2025 | To consider the approval, by an advisory vote, of the compensation of our named executive officers as disclosed in the Proxy Statement ("say-on-pay"). Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 11 funds |
| CASSAVA SCIENCES INC. | May 23, 2025 | To approve, by a non-binding advisory vote, 2024 executive compensation for the Company's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| CATALYST PHARMACEUTICALS INC. | May 20, 2025 | To approve, on an advisory basis, the 2024 compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 11 funds |
| CATHAY GENERAL BANCORP | May 12, 2025 | Approval, on a non-binding advisory basis, of the compensation paid to Cathay General Bancorp's named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 9 funds |
| CELCUITY INC. | May 13, 2025 | To approve, by a non-binding and advisory vote, compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| CENTURI HOLDINGS INC. | April 16, 2025 | Approval, on a non-binding, advisory basis, of executive compensation. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| CENTURY ALUMINUM CO. | June 16, 2025 | Proposal to approve, on an advisory basis, the compensation of the named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 8 funds |
| CERUS CORP. | June 3, 2025 | The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| CEVA INC. | May 5, 2025 | To approve an amendment and restatement of the Company's 2011 Equity Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CHARGEPOINT HOLDINGS INC. | July 9, 2024 | The advisory approval of the compensation of our named executive officers ("Say-on-Pay"). Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 7 funds |
| CHEGG INC. | June 4, 2025 | To approve the Chegg, Inc. Amendment to the 2023 Equity Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| CHEMED CORP. | May 19, 2025 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 10 funds |
| CHEMUNG FINANCIAL CORP. | June 3, 2025 | To approve the Chemung Financial Corporation 2025 Equity Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CHEMUNG FINANCIAL CORP. | June 3, 2025 | To approve, on a non-binding advisory basis, the compensation of the Named Executive Officers of the Corporation ("Say-on-Pay"). Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 3 funds |
| CHEWY | July 11, 2024 | To approve the Chewy, Inc. 2024 Omnibus Incentive Plan, including an increase in the number of shares reserved for issuance by 80,000,000 shares. Compensation |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CHILDREN'S PLACE INC. | May 7, 2025 | To approve, by non-binding vote, executive compensation as described in the proxy statement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| CHURCHILL DOWNS INC. | April 22, 2025 | To approve, on a non-binding advisory basis, the Company's executive compensation as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 8 funds |
| CIBUS INC. | May 22, 2025 | To approve, on an advisory basis, the compensation of the company's Named Executive Officers Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| CIDARA THERAPEUTICS INC. | June 18, 2025 | Approval of an amendment to the Company's 2024 Equity Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CIMPRESS PLC | November 20, 2024 | Amend Cimpress' 2020 Equity Incentive Plan to increase the number of ordinary shares issuable under the plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 3 funds |
| CIMPRESS PLC | November 20, 2024 | Reappoint Dessislava Temperley to Cimpress' Board of Directors to serve for a term of three years. Director Elections |
Board | For | AGAINST 3 funds |
FOR 3 funds |
| CIRRUS LOGIC INC. | July 26, 2024 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 10 funds |
| CITI TRENDS INC. | June 5, 2025 | Vote to approve an Amendment to the 2021 Incentive Plan to increase the number of shares available by 500,000 for grant. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CITIZENS FINANCIAL SERVICES INC. | April 15, 2025 | Advisory vote to approve the compensation of the Company's named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| CLARIVATE PLC | May 7, 2025 | APPROVAL OF THE CLARIVATE PLC AMENDED AND RESTATED 2019 INCENTIVE AWARD PLAN. Compensation |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| CLARKSON PLC | May 1, 2025 | Re-elect Laurence Hollingworth as Director Director Elections |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| CLARKSON PLC | May 1, 2025 | Re-elect Martine Bond as Director Director Elections |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| CLARKSON PLC | May 1, 2025 | Re-elect Tim Miller as Director Director Elections |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| CLEAR SECURE INC. | June 5, 2025 | Approval of, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 7 funds |
| CLEARPOINT NEURO INC. | May 21, 2025 | An advisory (non-binding) vote to approve the compensation of ClearPoint Neuro, Inc.'s named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| CNH INDUSTRIAL N V | May 12, 2025 | Approval of executive compensation ("Say on Pay") (advisory voting item) Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 10 funds |
| COASTAL FINANCIAL CORP. | May 28, 2025 | Advisory (non-binding) approval of the compensation paid to named executive officers. Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 5 funds |
| COGENT BIOSCIENCES INC. | June 4, 2025 | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| COLLEGIUM PHARMACEUTICAL INC. | May 15, 2025 | Approval of, on an advisory basis, the compensation of the Company's named executive officers Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 11 funds |
| COLLEGIUM PHARMACEUTICAL INC. | May 15, 2025 | To approve the Collegium Pharmaceutical, Inc. 2025 Equity Incentive Plan Compensation |
Board | For | AGAINST 3 funds |
FOR 7 funds |
| COLONY BANKCORP INC. | May 22, 2025 | To approve, on an advisory non-binding basis, the compensation of the Company's named executive officers as disclosed in the enclosed Proxy Statement. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| COMMERCE BANCSHARES INC. | April 25, 2025 | Advisory approval of the Company's executive compensation ("Say on Pay"). Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 7 funds |
| COMMUNITY | May 1, 2025 | To approve, on a non-binding advisory basis, the following resolutions: RESOLVED, that the stockholders of Community Healthcare Trust Incorporated approve, on a non-binding advisory basis, the compensation of the named executive officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2025 annual meeting of stockholders. Say-on-Pay |
Board | Not determined | FOR 5 funds |
AGAINST 5 funds |
| COMMUNITY WEST BANCSHARES | May 21, 2025 | To adopt a non-binding advisory resolution approving executive compensation. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| COMPASS INC. | May 22, 2025 | Advisory Vote to Approve 2024 Named Executive Officer Compensation ("Say-on-Pay Vote") Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| CONCRETE PUMPING HOLDINGS INC. | April 22, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 4 funds |
| CONMED COR | May 20, 2025 | Advisory Vote on Named Executive Officer Compensation; Say-on-Pay |
Board | Not determined | FOR 6 funds |
AGAINST 5 funds |
| CONSTRUCCIONES Y AUXILIAR DE FERROCARRILES SA | June 14, 2025 | Reelect Julian Gracia Palacin as Director Director Elections |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| COOPER-STANDARD HOLDINGS INC. | May 15, 2025 | Advisory Vote on Named Executive Officer Compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 3 funds |
| CORBUS PHARMACEUTICALS HOLDINGS INC. | May 15, 2025 | Approval, on an advisory basis, of the executive compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| CORCEPT THERAPEUTICS INC. | June 10, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 8 funds |
| CORE NATUR | April 29, 2025 | Approval, on an Advisory Basis, of the Compensation Paid to Core Natural Resources, Inc.'s Named Executive Officers in 2024. Say-on-Pay |
Board | Not determined | FOR 8 funds |
AGAINST 9 funds |
| CORMEDIX INC. | November 21, 2024 | To approve on a non-binding advisory basis the compensation of our named executive officers for 2023. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| CORMEDIX INC. | June 24, 2025 | To approve on a non-binding advisory basis the compensation of our named executive officers for 2024. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| CORVUS PHARMACEUTICALS INC. | June 12, 2025 | To approve, on a non-binding advisory basis, the compensation of our named executive officers Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| COUCHBASE INC. | May 29, 2025 | Approval, on an advisory, non-binding basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| COUPANG INC. | June 12, 2025 | To consider a non-binding vote to approve the compensation of Coupang, Inc.'s named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 8 funds |
| CPI CARD GROUP INC. | May 21, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| CREDIT ACCEPTANCE CORP. | June 4, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| CREDO TECHNOLOGY GROUP HOLDING LTD. | October 21, 2024 | To approve, on a non-binding advisory basis the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 6 funds |
| CRINETICS PHARMACEUTICALS INC. | June 11, 2025 | To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 4 funds |
| CULLEN/FROST BANKERS INC. | April 30, 2025 | To provide nonbinding approval of executive compensation; Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 10 funds |
| CULLINAN THERAPEUTICS INC. | June 12, 2025 | Proposal to vote, on an advisory basis, to approve our named executive officer compensation. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 4 funds |
| CVR ENERGY INC. | June 5, 2025 | To approve the Third Amended & Restated CVR Energy, Inc. 2007 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 5 funds |
| CYTOKINETICS INC. | May 14, 2025 | To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 7 funds |
| DAKTRONICS INC. | September 4, 2024 | Non-binding advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 4 funds |
| DANIMER SCIENTIFIC INC. | July 9, 2024 | Approval of an amendment to the Company's 2020 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| DARDEN RESTAURANTS INC. | September 18, 2024 | To obtain non-binding advisory approval of the Company's executive compensation. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 20 funds |
| DAVE & BUSTER'S ENTERTAINMENT INC. | June 18, 2025 | Approval of 2025 Omnibus Incentive Plan Compensation |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| DEERE & CO. | February 26, 2025 | Advisory vote to approve executive compensation ("say-on-pay") Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 22 funds |
| DIGI INTERNATIONAL INC. | February 3, 2025 | Company proposal to approve the amendment and restatement of the Digi International Inc. 2021 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| DIGITALOCEAN HOLDINGS INC. | June 9, 2025 | Election of Class I Director: Padmanabhan Srinivasan Director Elections |
Board | For | WITHHOLD 4 funds |
FOR 4 funds |
| DINE BRANDS GLOBAL INC. | May 14, 2025 | Approval, on an advisory basis, of the compensation of the Corporation's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| DIODES INC. | May 12, 2025 | To approve, on an advisory basis, the Company's executive compensation. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 6 funds |
| DIVERSIFIED HEALTHCARE TRUST | May 29, 2025 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 5 funds |
| DOLE PLC | May 21, 2025 | Election of Director: Rose Hynes Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 3 funds |
| DOLLAR TREE INC. | June 19, 2025 | To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 20 funds |
| DORIAN LPG LTD. | September 20, 2024 | Approval, on an advisory, non-binding basis, of the compensation of our named executive officers, as disclosed in this proxy statement. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 11 funds |
| DOUGLAS DY | April 29, 2025 | Advisory vote (non-binding) to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | Not determined | FOR 6 funds |
AGAINST 5 funds |
| DOXIMITY INC. | August 29, 2024 | To approve, on a non-binding advisory basis, the compensation paid to the Company's named executive officers in fiscal year 2024. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| DREAM FINDERS HOMES INC. | June 9, 2025 | Approval of an advisory resolution approving executive compensation for fiscal year 2024. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 6 funds |
← Previous Page 2 of 13 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.